Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NV › Las Vegas › NPI 1689611774
Hospital

Sunrise Hospital and Medical Center, LLC

Sunrise Hospital and Medical Center, LLC was paid $17.21M by Medicaid between Jan 2018 and Dec 2024, across 240 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoSUNRISE HOSPITAL AND MEDICAL CENTER, LLC
LAS VEGAS, NV 89109
33aNPI1689611774assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.21M
24GClaims1,015,575
24DCodes billed240
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Nevada

Rank by total paid#14 of 36
Median peer was paid$7.64M
This provider vs. median2.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018158,598$2.51M
2019182,257$2.65M
2020139,848$2.09M
2021131,117$1.96M
2022138,269$2.81M
2023189,055$3.74M
2024incomplete76,431$1.45M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 45,887 38,463 $4.16M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 42,744 37,169 $2.37M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 20,639 16,175 $1.84M
74177 Computed tomography, abdomen and pelvis; with contrast material 11% 6,973 6,024 $1.82M
70450 Computed tomography, head or brain; without contrast material 7.4% 10,648 9,221 $1.28M
G0378 Hospital observation service, per hour 5.8% 10,158 6,667 $995K
97530 Therapeutic activities, direct patient contact, each 15 minutes 5.3% 19,963 3,687 $907K
96361 Intravenous infusion, hydration; each additional hour 2.7% 17,460 12,991 $460K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.3% 814 631 $402K
71275 Computed tomographic angiography, chest, with contrast material 2.3% 2,111 1,779 $391K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 2,091 1,845 $388K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 7,996 7,415 $252K
228 more codes
93975 <1% 4,128 $144K
70486 <1% 615 $131K
70551 Magnetic resonance imaging, brain; without contrast material <1% 622 $113K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 23,513 $90K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 335 $86K
72125 Computed tomography, cervical spine; without contrast material <1% 3,879 $85K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 7,353 $68K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,110 $67K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,797 $62K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,833 $53K
76770 <1% 910 $51K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,248 $42K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 14,175 $38K
71046 Radiologic examination, chest; 2 views <1% 9,677 $37K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 3,856 $35K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 6,732 $34K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,985 $30K
80053 Comprehensive metabolic panel <1% 41,055 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 13,806 $29K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,921 $28K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 39,595 $28K
71045 Radiologic examination, chest; single view <1% 24,716 $28K
96375 Therapeutic injection; each additional sequential IV push <1% 15,753 $27K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,133 $26K
87186 <1% 1,445 $24K
76830 Ultrasound, transvaginal <1% 1,374 $22K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,574 $21K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 521 $21K
70498 <1% 49 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,037 $20K
85027 <1% 65,474 $19K
99153 Mod sedat endo service >5yrs <1% 1,408 $17K
73564 <1% 2,458 $14K
95819 <1% 157 $14K
99213 Doctor's office visit, returning patient (routine) <1% 405 $14K
74018 <1% 3,052 $13K
87040 <1% 9,668 $11K
83880 <1% 8,833 $11K
84484 <1% 30,710 $11K
93971 <1% 1,378 $10K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,254 $10K
80048 Basic metabolic panel (calcium, ionized) <1% 18,756 $9K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 71 $9K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 172 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,585 $8K
97163 <1% 372 $8K
73130 <1% 1,698 $8K
84703 <1% 14,739 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 26,627 $8K
73610 <1% 1,471 $7K
93458 <1% 18 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,562 $7K
83690 <1% 18,062 $7K
73630 <1% 1,783 $6K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,565 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 216 $6K
96376 <1% 7,308 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,548 $6K
81001 <1% 23,397 $6K
72100 <1% 1,796 $6K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 322 $5K
73502 <1% 631 $5K
86923 <1% 592 $5K
93970 <1% 641 $5K
74019 <1% 1,124 $5K
87486 <1% 1,158 $5K
87581 <1% 1,159 $5K
70491 <1% 13 $5K
87430 <1% 2,451 $5K
84702 <1% 4,274 $5K
87070 <1% 2,517 $4K
73030 <1% 1,630 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,018 $4K
71250 <1% 16 $4K
73110 <1% 442 $4K
84443 Thyroid stimulating hormone (TSH) <1% 3,448 $3K
12011 <1% 141 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,528 $3K
76870 <1% 57 $3K
70496 <1% 15 $3K
87400 <1% 2,768 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 476 $3K
83605 <1% 4,980 $3K
73080 <1% 296 $2K
73090 <1% 352 $2K
81025 <1% 5,516 $2K
73590 <1% 366 $2K
80076 <1% 11,745 $2K
72131 <1% 14 $2K
92523 <1% 15 $2K
12001 <1% 124 $2K
80047 <1% 14,148 $2K
85730 <1% 15,291 $2K
96368 <1% 847 $2K
83735 <1% 8,528 $2K
72072 <1% 359 $2K
87077 <1% 1,840 $2K
85610 <1% 22,184 $2K
82805 <1% 1,198 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 815 $2K
12002 <1% 57 $2K
C1769 Guide wire <1% 1,254 $1K
80061 Lipid panel <1% 2,358 $1K
82550 <1% 12,969 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,757 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,737 $1K
86140 <1% 3,256 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 342 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,329 $1K
97162 <1% 130 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 10,948 $1K
36430 <1% 216 $1K
84112 <1% 180 $1K
82077 <1% 6,214 $1K
86901 <1% 7,775 $1K
86900 <1% 7,775 $1K
10060 <1% 41 $1K
85379 <1% 1,368 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,023 $958.58
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,450 $874.72
87808 <1% 395 $867.08
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 7,959 $859.49
82728 <1% 133 $832.83
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,080 $759.83
81003 <1% 6,733 $729.86
97167 <1% 17 $714.76
86850 <1% 4,959 $686.31
72050 <1% 107 $664.07
J7050 Infusion, normal saline solution, 250 cc <1% 8,675 $647.42
83036 Hemoglobin; glycosylated (A1C) <1% 2,644 $615.66
87205 <1% 2,256 $578.78
87420 <1% 474 $556.24
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,080 $555.37
84100 <1% 3,143 $529.72
29125 <1% 27 $527.80
71101 <1% 89 $515.82
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 141 $513.10
93017 <1% 837 $455.39
99152 <1% 748 $453.70
P9016 Red blood cells, leukocytes reduced, each unit <1% 15 $450.91
S0028 Injection, famotidine, 20 mg <1% 1,097 $403.08
97116 <1% 36 $387.32
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,302 $376.84
82330 <1% 659 $357.45
96367 <1% 40 $346.97
J8540 Dexamethasone, oral, 0.25 mg <1% 463 $343.11
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,634 $315.93
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,097 $307.11
82140 <1% 610 $298.20
J3370 Injection, vancomycin hcl, 500 mg <1% 1,075 $293.93
82248 <1% 2,232 $287.28
97161 <1% 41 $282.20
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 79 $262.88
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 833 $248.34
J1170 Injection, hydromorphone, up to 4 mg <1% 3,832 $238.33
73552 <1% 14 $237.17
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 991 $224.87
86920 <1% 54 $219.26
J0456 Injection, azithromycin, 500 mg <1% 1,092 $213.55
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,059 $204.32
87088 <1% 756 $199.91
85651 <1% 942 $193.08
97168 <1% 16 $183.62
J1644 Injection, heparin sodium, per 1000 units <1% 995 $173.98
80329 <1% 513 $172.20
J1630 Injection, haloperidol, up to 5 mg <1% 3,670 $171.03
J2060 Injection, lorazepam, 2 mg <1% 6,396 $166.98
84439 <1% 305 $166.05
J1953 Injection, levetiracetam, 10 mg <1% 280 $140.00
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,428 $139.22
80069 <1% 48 $130.06
80074 <1% 59 $130.00
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 686 $108.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 984 $97.43
J2704 Injection, propofol, 10 mg <1% 1,420 $94.80
J1815 Injection, insulin, per 5 units <1% 2,948 $89.94
J0360 Injection, hydralazine hcl, up to 20 mg <1% 350 $78.10
74021 <1% 97 $77.46
84132 <1% 475 $75.28
92610 <1% 24 $64.15
73060 <1% 18 $62.16
95700 <1% 31 $55.39
J1650 Injection, enoxaparin sodium, 10 mg <1% 383 $53.52
93320 <1% 43 $48.56
J0692 Injection, cefepime hydrochloride, 500 mg <1% 55 $45.96
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 86 $35.00
J0690 Injection, cefazolin sodium, 500 mg <1% 374 $33.07
J1790 Injection, droperidol, up to 5 mg <1% 133 $31.02
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 14 $27.36
93325 <1% 44 $23.37
J3475 Injection, magnesium sulfate, per 500 mg <1% 31 $22.44
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 374 $15.24
82310 <1% 291 $14.08
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 15 $8.80
85045 <1% 147 $8.19
82553 <1% 607 $8.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,670 $6.73
J1940 Injection, furosemide, up to 20 mg <1% 303 $6.16
85384 <1% 27 $5.79
83550 <1% 50 $4.78
83540 <1% 66 $3.89
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 439 $2.92
85007 <1% 328 $2.35
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,154 $1.78
J3490 Unclassified drugs <1% 652 $0.17
J3486 Injection, ziprasidone mesylate, 10 mg 0% 154 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 294 $0.00
87631 0% 972 $0.00
90715 0% 424 $0.00
99151 0% 153 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 0% 168 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 113 $0.00
87150 0% 29 $0.00
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 0% 640 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 27 $0.00
90714 0% 252 $0.00
82009 0% 123 $0.00
J0670 Injection, mepivacaine hydrochloride, per 10 ml 0% 15 $0.00
80320 0% 4,711 $0.00
A9270 Non-covered item or service 0% 13,571 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 21 $0.00
86945 0% 100 $0.00
86905 0% 30 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 28 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 24 $0.00
36415 Collection of venous blood by venipuncture 0% 222 $0.00
85660 0% 13 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 20 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialARAD, LANA (CFO)
Same official

Other billing entities under ARAD, LANA

Full network →
ProviderLocationPaid
Sunrise Hospital and Medical Center, LLCLas Vegas, NV$254K
Sunrise Hospital and Medical Center, LLCLas Vegas, NV$101K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.